GlassScriptPhysician profile
Joseph M Hadi
NPI 1972762227
$2,981.67
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.13 · 2020: $151 · 2021: $297 · 2022: $570 · 2023: $111 · 2024: $1,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,073 · Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,073.09 |
| Food and Beverage | $869.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $1,096.83 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $548.80 | 2022 | |
| Inari Medical, INC. | $491.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Spr Therapeutics, INC | $242.88 | 2024 | Sprint Pns System |
| Mallinckrodt Hospital Products INC. | $150.00 | 2020-2021 | |
| Ibsa Pharma INC. | $96.39 | 2023 | Licart |
| Amgen INC. | $89.41 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $68.06 | 2020-2022 | |
| Boston Scientific Corporation | $52.49 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Alexion Pharmaceuticals, INC. | $50.00 | 2021 | |
| Merz North America, INC. | $50.00 | 2020 | |
| Sk Life Science, INC. | $25.00 | 2020 | |
| Lilly USA, LLC | $20.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.